scispace - formally typeset
D

Dominique Stoppa-Lyonnet

Researcher at Curie Institute

Publications -  444
Citations -  32995

Dominique Stoppa-Lyonnet is an academic researcher from Curie Institute. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 80, co-authored 420 publications receiving 29316 citations. Previous affiliations of Dominique Stoppa-Lyonnet include PSL Research University & Bosch.

Papers
More filters
Journal ArticleDOI

Reply to prophylactic salpingo‐oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation

TL;DR: This study shows that prophylactic SO remains an important option for BRCA1/2 mutation carriers as asymptomatic ovarian/fallopian cancers were found in 4.5% of patients, and longer follow-up and larger series are required to more precisely evaluate the benefits of this procedure in terms of BC incidence, peritoneal malignancy, or recurrence.
Journal ArticleDOI

Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition.

TL;DR: This review summarizes the available data on the impact of variants on non-coding regions of BRCA1/2 genes and their role on breast and ovarian cancer predisposition.
Journal ArticleDOI

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Antoinette Hollestelle, +391 more
- 01 May 2016 - 
TL;DR: Genotyping rs61764370 is not associated with risk of ovarian or breast cancer nor with clinical outcome for patients with these cancers, and genotyping this variant has no clinical utility related to the prediction or management of these cancers.
Journal ArticleDOI

Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers

Amanda B. Spurdle, +80 more
TL;DR: Evidence to date does not support a role for BARD1 variation, including the Cy557Ser variant, as a modifier of risk in BRCA1/2 mutation carriers, according to single SNP analysis.